OpenAlex
PricingAboutJobs
Log inGet started
Work

Risk of Lymphoma Associated With Combination Anti–Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis

HTML

Year: 2009
Type: review
Study designs: Systematic Review, Meta-Analysis
Source: Clinical Gastroenterology and Hepatology
DOI: 10.1016/j.cgh.2009.01.004
Authors: Corey A. Siegel, Sadie M. Marden, Sarah M. Persing, Robin J. Larson, Bruce E. Sands
Institutions: Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth–Hitchcock Medical Center, Dartmouth Health, Harvard University, Massachusetts General Hospital
Language: English

Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Keywords: Crohn's disease, non-Hodgkin lymphoma, anti-TNF therapy, immunomodulators, combination therapy, lymphoma risk, adverse drug reactions, SEER database, standardized incidence ratio
SDG: Good health and well-being

Open Access status: green

Funders: Crohn's and Colitis Foundation of America, Otsuka America Pharmaceutical, Crohn's and Colitis Foundation, Otsuka America, Otsuka Pharmaceutical, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
Award: Risk Communication in Crohn's Disease
OpenAlex ID: W2105532585
FWCI: 6.874
Cites: 46
Cited by: 547
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms